Beijing StoneWise Technology Co., Ltd
1 clinical trials · Sponsor
◉ Watch Beijing StoneWise Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors (NCT07363967) | Beijing StoneWise Technology Co., Ltd | 2025-06-13 |
Track Beijing StoneWise Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.